Market Tracker

04/24 6:02pm ET

Immunomedics Inc (NASDAQ:IMMU)

4.09
Delayed Data
As of Apr 24
 -0.02 / -0.49%
Today’s Change
3.04
Today|||52-Week Range
5.48
-14.79%
Year-to-Date

Today’s Trading

Previous close4.11
Today’s open4.09
Day’s range4.08 - 4.22
Volume408,339
Average volume (3 months)1,048,646
Market cap$382.0M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book9.72

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd+0.24+2.13%
CLDNCelladon Corp-0.26-1.87%
ENTLEntellus Medical Inc+0.44+1.63%
ARDXArdelyx Inc-0.49-3.95%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts